The invention relates to TGF-.beta. blocking agent-treated HSC compositionsand methods comprising the same. The TGF-.beta. blocking agent-treated stemcells are viable for an extended time in culture without replication ordifferentiation and upon transfer to appropriate conditions are capable oflong term hematopoietic reconstitution.